Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
482
8.370
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
81
3.570
 Why?
Immunologic Factors
13
2025
256
2.430
 Why?
Neurology
10
2018
110
2.200
 Why?
Immunosuppressive Agents
10
2024
843
1.540
 Why?
Neuromyelitis Optica
4
2023
136
1.090
 Why?
Natalizumab
11
2021
40
0.910
 Why?
Recurrence
8
2025
1122
0.860
 Why?
Diagnostic Errors
2
2017
176
0.680
 Why?
Brain
16
2025
2901
0.650
 Why?
Internship and Residency
5
2011
1245
0.620
 Why?
Drug Substitution
2
2019
62
0.620
 Why?
Fingolimod Hydrochloride
5
2020
39
0.610
 Why?
Data Collection
4
2011
636
0.580
 Why?
Rituximab
4
2020
210
0.570
 Why?
Magnetic Resonance Imaging
25
2026
3834
0.570
 Why?
Dementia, Vascular
3
2009
21
0.560
 Why?
Medication Adherence
2
2019
519
0.520
 Why?
Early Medical Intervention
1
2017
61
0.510
 Why?
Early Diagnosis
2
2017
247
0.500
 Why?
Glatiramer Acetate
6
2019
18
0.480
 Why?
Calcinosis
2
2009
235
0.470
 Why?
Humans
88
2026
143817
0.470
 Why?
Physicians
4
2016
932
0.460
 Why?
Drug Monitoring
1
2019
394
0.460
 Why?
Postural Balance
3
2018
246
0.430
 Why?
Antibodies, Monoclonal, Humanized
8
2023
982
0.400
 Why?
Neuroimaging
2
2026
286
0.370
 Why?
Fatigue
3
2018
356
0.370
 Why?
Dimethyl Fumarate
3
2020
12
0.350
 Why?
Immunoglobulin G
4
2023
899
0.340
 Why?
Practice Guidelines as Topic
1
2018
1525
0.320
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.320
 Why?
Middle Aged
39
2025
35629
0.310
 Why?
Withholding Treatment
2
2021
79
0.310
 Why?
Adult
44
2026
40128
0.310
 Why?
Psychiatry
2
2009
186
0.290
 Why?
Demyelinating Diseases
4
2019
84
0.280
 Why?
Cysts
1
2009
111
0.280
 Why?
HIV Long Terminal Repeat
3
2001
11
0.270
 Why?
Education, Medical
1
2011
270
0.270
 Why?
Autoantibodies
3
2023
1497
0.270
 Why?
Certification
1
2008
119
0.260
 Why?
Lymphopenia
2
2020
69
0.260
 Why?
Education
2
2007
107
0.250
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
77569
0.250
 Why?
Clinical Trials as Topic
3
2016
1047
0.240
 Why?
Cerebral Arteries
1
2006
58
0.240
 Why?
Leukoencephalopathies
1
2026
24
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
53
0.240
 Why?
Single-Blind Method
3
2023
308
0.240
 Why?
Male
40
2025
71568
0.240
 Why?
Cerebrovascular Disorders
1
2006
102
0.230
 Why?
DNA, Viral
2
1998
361
0.230
 Why?
Drug Industry
2
2016
48
0.230
 Why?
Ethics, Medical
2
2015
84
0.230
 Why?
Societies, Medical
4
2019
865
0.230
 Why?
Conflict of Interest
2
2016
49
0.220
 Why?
HIV Seropositivity
2
1998
118
0.220
 Why?
Treatment Outcome
12
2023
11459
0.210
 Why?
White Matter
1
2026
150
0.210
 Why?
Databases, Factual
3
2016
1459
0.210
 Why?
Double-Blind Method
4
2023
2017
0.200
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Microglia
2
2024
267
0.190
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
66
0.190
 Why?
Heart Aneurysm
1
2002
12
0.180
 Why?
Quality of Health Care
2
2017
649
0.180
 Why?
Heart Septal Defects, Atrial
1
2002
58
0.170
 Why?
B-Lymphocytes
5
2023
889
0.170
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
234
0.170
 Why?
Education, Medical, Continuing
2
2015
130
0.170
 Why?
Mental Disorders
2
2007
1127
0.160
 Why?
Central Nervous System Neoplasms
2
2005
172
0.160
 Why?
Agammaglobulinemia
1
2020
35
0.160
 Why?
Brain Neoplasms
4
2016
1307
0.160
 Why?
Interferon-gamma
1
2023
791
0.160
 Why?
Serum Sickness
1
2019
4
0.150
 Why?
Indans
1
2019
13
0.150
 Why?
Oxadiazoles
1
2019
36
0.150
 Why?
Neutropenia
1
2020
155
0.150
 Why?
Disease Progression
4
2021
2871
0.150
 Why?
Diagnosis, Differential
4
2023
1502
0.150
 Why?
Referral and Consultation
1
2005
839
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
246
0.140
 Why?
Salvage Therapy
1
2019
156
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
258
0.140
 Why?
Herpesvirus 8, Human
1
1998
67
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
3
0.130
 Why?
Eye Movements
1
2018
92
0.130
 Why?
Educational Measurement
3
2015
322
0.130
 Why?
Physician-Patient Relations
2
2016
585
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Central Nervous System
2
2005
272
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
681
0.130
 Why?
Patient Selection
2
2015
695
0.130
 Why?
Young Adult
7
2024
13914
0.130
 Why?
Herpesvirus 4, Human
1
2018
173
0.130
 Why?
Herpesviridae Infections
1
1998
149
0.120
 Why?
Nervous System Diseases
2
2024
280
0.120
 Why?
Suicide, Assisted
1
1997
30
0.120
 Why?
Neurologists
1
2016
22
0.120
 Why?
Costs and Cost Analysis
1
2017
215
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
616
0.120
 Why?
Aged
9
2024
25616
0.120
 Why?
Dizziness
2
2018
94
0.110
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
72
0.110
 Why?
Retrospective Studies
10
2024
16755
0.110
 Why?
T-Lymphocytes
1
2023
2041
0.110
 Why?
Follow-Up Studies
6
2020
5317
0.110
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
155
0.110
 Why?
Trust
1
2016
151
0.100
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
59
0.100
 Why?
Medication Reconciliation
1
2013
31
0.100
 Why?
CD40 Antigens
1
2014
90
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
135
0.100
 Why?
Insurance, Health
1
2016
296
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Exercise Therapy
1
2018
465
0.100
 Why?
Stroke
1
2002
1219
0.100
 Why?
Anti-Inflammatory Agents
2
2006
483
0.100
 Why?
Sensation Disorders
1
2012
41
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
19
0.090
 Why?
Population Surveillance
1
2016
491
0.090
 Why?
Memory Disorders
1
2013
195
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
85
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
19
0.090
 Why?
HIV-1
2
2001
904
0.090
 Why?
Optic Nerve
2
2005
65
0.090
 Why?
T-Lymphocyte Subsets
1
2014
421
0.090
 Why?
Glioma
1
2016
424
0.090
 Why?
Gadolinium
4
2018
86
0.080
 Why?
United States
8
2024
15602
0.080
 Why?
Academies and Institutes
1
2011
61
0.080
 Why?
Self-Assessment
1
2011
77
0.080
 Why?
Learning
1
2015
447
0.080
 Why?
Nerve Regeneration
1
2010
58
0.080
 Why?
Fatal Outcome
3
2006
306
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Diagnostic Tests, Routine
1
2011
110
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
Antigens, CD19
3
2007
139
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Biomarkers
3
2014
4248
0.080
 Why?
Exercise Test
1
2012
621
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Quality of Life
3
2021
3141
0.080
 Why?
Severity of Illness Index
3
2014
2925
0.080
 Why?
Disease Management
1
2013
639
0.070
 Why?
Guidelines as Topic
1
2011
270
0.070
 Why?
Spinal Cord
3
2023
381
0.070
 Why?
Neuroprotective Agents
1
2009
145
0.070
 Why?
Physical Therapy Modalities
1
2011
328
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1322
0.070
 Why?
Immunoglobulin Variable Region
2
2004
80
0.070
 Why?
Workload
1
2009
167
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
15
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Neuropsychological Tests
2
2013
1122
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1133
0.060
 Why?
Antibodies, Monoclonal
2
2011
1522
0.060
 Why?
Methylprednisolone
1
2006
63
0.060
 Why?
Medical Records
1
2007
183
0.060
 Why?
Syndrome
2
2023
373
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
111
0.060
 Why?
International Classification of Diseases
1
2007
140
0.060
 Why?
Antibody Formation
1
2007
294
0.060
 Why?
Huntington Disease
1
2007
61
0.060
 Why?
Herpes Zoster
1
2010
315
0.060
 Why?
Contrast Media
3
2018
486
0.060
 Why?
Intracranial Hemorrhages
1
2006
98
0.060
 Why?
Aquaporin 4
1
2006
97
0.060
 Why?
Adolescent
8
2024
22233
0.060
 Why?
DNA Mutational Analysis
1
2006
408
0.060
 Why?
Canada
2
2019
425
0.060
 Why?
Health Care Surveys
1
2007
535
0.060
 Why?
Analysis of Variance
3
2015
1308
0.060
 Why?
Teaching
1
2007
230
0.050
 Why?
Neurologic Examination
1
2005
129
0.050
 Why?
Fellowships and Scholarships
1
2009
346
0.050
 Why?
Cognition Disorders
1
2009
542
0.050
 Why?
Patient Compliance
1
2009
612
0.050
 Why?
RNA, Messenger
1
1992
2847
0.050
 Why?
Surveys and Questionnaires
4
2016
6004
0.050
 Why?
Program Evaluation
1
2009
947
0.050
 Why?
Central Nervous System Diseases
1
2005
75
0.050
 Why?
Colorado
2
2024
4578
0.050
 Why?
Affect
1
2007
318
0.050
 Why?
Simvastatin
1
2004
58
0.050
 Why?
Neutrophils
1
2010
1144
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Erythrocytes
1
2010
757
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Prevalence
2
2024
2819
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
294
0.050
 Why?
B-Lymphocyte Subsets
1
2003
80
0.050
 Why?
Cyclophosphamide
1
2003
267
0.050
 Why?
Radiography
1
2005
838
0.050
 Why?
Neurodegenerative Diseases
1
2024
141
0.050
 Why?
Academic Medical Centers
1
2005
537
0.040
 Why?
Infusions, Intravenous
1
2023
427
0.040
 Why?
Patient Outcome Assessment
1
2023
133
0.040
 Why?
Membrane Glycoproteins
1
2004
499
0.040
 Why?
Lymphoma, B-Cell
2
2005
136
0.040
 Why?
Students, Medical
1
2006
375
0.040
 Why?
Pain
1
2007
776
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
276
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
38
0.040
 Why?
Anticoagulants
1
2006
718
0.040
 Why?
Molecular Sequence Data
3
2004
2914
0.040
 Why?
Disability Evaluation
2
2014
306
0.040
 Why?
Single-Cell Analysis
1
2024
360
0.040
 Why?
Peptides
3
2013
986
0.040
 Why?
Cross-Sectional Studies
1
2012
5761
0.040
 Why?
Antibodies, Antinuclear
1
2001
61
0.040
 Why?
Schools, Medical
1
2002
158
0.040
 Why?
Atrophy
1
2021
199
0.040
 Why?
Dementia
1
2005
296
0.040
 Why?
Time Factors
4
2018
7068
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
162
0.040
 Why?
Clinical Competence
1
2008
1226
0.040
 Why?
Mobility Limitation
1
2020
66
0.040
 Why?
Venous Thrombosis
1
2002
194
0.040
 Why?
Child
5
2016
22441
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1143
0.040
 Why?
Antibodies, Viral
1
2023
684
0.040
 Why?
Maintenance Chemotherapy
1
2019
42
0.040
 Why?
Cerebral Infarction
1
1998
48
0.040
 Why?
Cell Separation
2
2014
311
0.040
 Why?
Induction Chemotherapy
1
2019
86
0.040
 Why?
Lipids
1
2023
699
0.030
 Why?
HIV Seronegativity
1
1998
30
0.030
 Why?
Genes, myc
1
1998
51
0.030
 Why?
Base Sequence
2
2001
2186
0.030
 Why?
Transplantation, Autologous
1
2019
290
0.030
 Why?
Astrocytoma
1
1998
131
0.030
 Why?
In Situ Hybridization
1
2018
320
0.030
 Why?
Gene Library
1
1997
126
0.030
 Why?
Risk Assessment
1
2006
3556
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
345
0.030
 Why?
Gene Rearrangement
1
1998
156
0.030
 Why?
Managed Care Programs
1
1997
135
0.030
 Why?
Syndecan-1
2
2007
41
0.030
 Why?
Drug Administration Schedule
1
2018
779
0.030
 Why?
Morals
1
1997
81
0.030
 Why?
Risk Factors
3
2008
10623
0.030
 Why?
Flow Cytometry
2
2014
1192
0.030
 Why?
Viral Load
1
2018
515
0.030
 Why?
Breast Neoplasms
1
2008
2497
0.030
 Why?
Mutation
1
2006
4106
0.030
 Why?
Polymerase Chain Reaction
1
1998
1057
0.030
 Why?
Survival Analysis
1
2018
1358
0.030
 Why?
Sequence Analysis, DNA
1
1997
828
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1402
0.030
 Why?
Child, Preschool
3
2016
11631
0.030
 Why?
Incidence
1
2020
2845
0.020
 Why?
Congresses as Topic
1
2015
228
0.020
 Why?
Patient Care Team
1
2019
676
0.020
 Why?
Propylene Glycols
1
2013
27
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
219
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
Quality-Adjusted Life Years
1
2013
114
0.020
 Why?
beta-Galactosidase
1
1992
77
0.020
 Why?
Drug Therapy, Combination
1
2015
1032
0.020
 Why?
Markov Chains
1
2013
125
0.020
 Why?
Mice, Inbred DBA
1
1992
188
0.020
 Why?
Leukocyte Count
1
1993
317
0.020
 Why?
Haplotypes
1
2014
490
0.020
 Why?
Organ Specificity
1
1992
308
0.020
 Why?
Reference Values
1
2013
806
0.020
 Why?
Comparative Effectiveness Research
1
2013
164
0.020
 Why?
CD3 Complex
1
2012
109
0.020
 Why?
Ki-67 Antigen
1
2012
122
0.020
 Why?
Thymus Gland
1
1992
317
0.020
 Why?
Mental Recall
1
2013
221
0.020
 Why?
Intestine, Small
1
1992
166
0.020
 Why?
Mitoxantrone
1
2011
15
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Mice
2
2023
18421
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
38140
0.020
 Why?
Patient Participation
1
2015
436
0.020
 Why?
Clinical Laboratory Techniques
1
2011
99
0.020
 Why?
Depression
2
2011
1520
0.020
 Why?
Recombinant Fusion Proteins
1
1992
683
0.020
 Why?
Amino Acid Sequence
2
2004
2148
0.020
 Why?
Physical Endurance
1
2011
281
0.020
 Why?
Acyclovir
1
2010
96
0.020
 Why?
Spinal Cord Neoplasms
1
1989
40
0.020
 Why?
Cell Count
1
2010
324
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1688
0.020
 Why?
History, 19th Century
1
2009
61
0.020
 Why?
Respiratory Function Tests
1
2011
570
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
57
0.020
 Why?
Aged, 80 and over
2
2016
8130
0.020
 Why?
Injections
1
2009
194
0.020
 Why?
History, 21st Century
1
2009
222
0.020
 Why?
Pilot Projects
2
2004
1851
0.020
 Why?
Autoimmunity
1
2014
925
0.020
 Why?
Electrocardiography
1
2011
635
0.020
 Why?
History, 20th Century
1
2009
327
0.020
 Why?
Gene Expression
1
1992
1512
0.020
 Why?
Mice, Transgenic
1
1992
2182
0.020
 Why?
Age of Onset
1
2009
543
0.020
 Why?
Health
1
2007
83
0.020
 Why?
Memory
1
2009
296
0.020
 Why?
Association Learning
1
2007
71
0.020
 Why?
Herpesvirus 3, Human
1
2010
333
0.020
 Why?
Cerebral Ventricles
1
2006
55
0.020
 Why?
Walking
1
2011
560
0.020
 Why?
Prognosis
2
2006
4211
0.010
 Why?
Motor Skills
1
2007
105
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
945
0.010
 Why?
Hypothalamus
1
2006
156
0.010
 Why?
Genetics
1
2005
22
0.010
 Why?
Phenotype
1
2014
3182
0.010
 Why?
Models, Theoretical
1
2009
586
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Immunologic Memory
1
2007
375
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
643
0.010
 Why?
Hospitalization
1
2015
2340
0.010
 Why?
Anisotropy
1
2004
77
0.010
 Why?
Clinical Protocols
1
2006
280
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
285
0.010
 Why?
Immune System
1
2005
182
0.010
 Why?
Internet
1
2009
699
0.010
 Why?
Plasma Cells
1
2004
75
0.010
 Why?
Antiviral Agents
1
2010
743
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Infrared Rays
1
2003
27
0.010
 Why?
Videotape Recording
1
2003
37
0.010
 Why?
Saccades
1
2003
45
0.010
 Why?
Antilymphocyte Serum
1
2003
61
0.010
 Why?
Oligoclonal Bands
1
2003
26
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Clone Cells
1
2003
269
0.010
 Why?
Whole-Body Irradiation
1
2003
78
0.010
 Why?
Astrocytes
1
2005
218
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
135
0.010
 Why?
Immunoglobulins
1
2003
163
0.010
 Why?
Observer Variation
1
2003
353
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
193
0.010
 Why?
Feasibility Studies
1
2006
1065
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Age Factors
1
2009
3288
0.010
 Why?
Mice, Inbred C57BL
1
1992
6032
0.010
 Why?
Administration, Oral
1
2004
841
0.010
 Why?
Consensus Sequence
1
2001
75
0.010
 Why?
Biopsy
1
2005
1068
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2782
0.010
 Why?
Longitudinal Studies
1
2009
2947
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
991
0.010
 Why?
Sex Characteristics
1
2007
786
0.010
 Why?
Cytomegalovirus Infections
1
2003
205
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
55
0.010
 Why?
Urinary Tract Infections
1
2003
201
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
100
0.010
 Why?
Infant
1
2015
9886
0.010
 Why?
Cohort Studies
1
2011
5862
0.010
 Why?
Acute Disease
1
2003
996
0.010
 Why?
Predictive Value of Tests
1
2006
2097
0.010
 Why?
Research
1
2003
426
0.010
 Why?
Combined Modality Therapy
1
2003
1261
0.010
 Why?
Lung
1
1992
4143
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1984
0.010
 Why?
Survival Rate
1
2003
2035
0.010
 Why?
Monocytes
1
2001
543
0.010
 Why?
Virus Replication
1
2001
537
0.010
 Why?
Binding Sites
1
2001
1312
0.010
 Why?
Models, Biological
1
2005
1833
0.010
 Why?
Case-Control Studies
1
2004
3614
0.010
 Why?
Aging
1
2007
1968
0.010
 Why?
Reproducibility of Results
1
2003
3392
0.010
 Why?
Transcription, Genetic
1
2001
1504
0.010
 Why?
DNA-Binding Proteins
1
2001
1493
0.010
 Why?
Cells, Cultured
1
2001
4172
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)